Please note that only presentations that have been approved for sharing by their originators are available online.
If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
Tuesday, 6 October 2015
International Conference on Clinical PET-CT and Molecular Imaging (IPET 2015)
Plenary Session IV
Hybrid Imaging and Other Imaging Techniques in Paediatrics
09.00 – 09.30
The Role of PET/CT Imaging in the Management of Paediatric Cancers?Robert Howman-Giles, Australia
09.30 – 10.00
Other Imaging Modalities in Paediatric Cancers?Helen Nadel, Canada
10.00 – 10.30
Dose Optimization in Paediatric Patients?Madan Rehani, USA
10.30 – 11.00
Read with the Expert: PET/CT, Paediatric Cancers?Robert Howman-Giles, Australia
11.00 – 11.20
Coffee Break, Poster and Exhibits Viewing
Plenary Session V
Ethics, Leadership, Education and Regulatory Issues
11.20 – 11.40
Ethical Issues in Diagnostic Imaging Practice?Sobhan Vinjamuri, BNMS, UK
11.40 – 12.00
Leadership Initiatives in Nuclear Medicine Practice?Akram Al-Ibraheem, ARSNM
12.00 – 12.20
Understanding How Learners Learn: Writing Learning Objectives for Educational Activities?Thomas Pascual, IAEA
12.20 – 12.35
Importance of CME Credits in the Lifelong Learning Process ?Teresio Varetto, Italy
12.35 – 13.00
US Production of PET Drugs for Clinical and Research Uses ?Sally Schwarz, SNMMI
Parallel Session 1a
14.00 – 14.40
PET/CT Imaging in Gastrointestinal Cancers?Stefano Fanti, EANM
14.40 – 15.20
Other Imaging Modalities in Gastrointestinal Cancers?Gabriele Masselli, ESR
15.20 – 16.00
Read with the Expert: PET/CT, Gastrointestinal Cancers?Jean Luc Urbain, CANM, Canada
Parallel Session 1b
14.00 – 14.30
PET Radiopharmaceuticals Beyond FDG?Jason S. Lewis, WMIS
14.30 – 15.00
64 Radiopharmaceuticals Production and Quality Control?Paola Panichelli, Italy
15.00 – 15.30
Ga 68 - Radiopharmaceuticals: Current Status and Future?Frank Roesch, Germany
15.30 – 16.00
Manufacturing Regulations for Imaging Radiopharmaceuticals in the United States?Orhan Suleiman, USA
Parallel Session 1c
14.00 – 14.30
Need of Tracking of Patient Doses in Nuclear Medicine and Hybrid Imaging?Madan Rehani, USA
14.30 – 14.50
IAEA Activities on Radiation Protection in Diagnostic Imaging?Jenia Vassileva, IAEA
14.50 – 15.15
QA/QC in PET: Accreditation, Daily QC and More?Ivo Rausch, Austria
15.15 – 15.40
Advances of Detector Technology in Nuclear Medicine?Satchithanantham Somanesan, SGH, Singapore
15.40 – 16.00
A Consideration of the Barriers and Potential of Data-Driven PET Innovation?Adam Kesner, WFNMB
Poster Review Session II
16.00 – 17.00
Meet-the-Authors: Poster Review?Thomas Pascual, IAEA
Reviewers:
- Robert Howman-Giles, Australia
- Teresio Varetto, Italy
- Mohamad Haidar, Lebanon
- Stefano Fanti, EANM
- Jean Luc Urbain, CANM, Canada
- Rathan Subramaniam, ACNM, USA
- Marc Seltzer, USA
- Batool Al-Balooshi, ARSNM
- Francesco Giammarile, France
Plenary Session VI
17.00 – 17.20
Optimization of Clinical Protocols?Kunthi Pathmaraj, WFNMB
17.20 – 17.40
Status of Mo-99 Supply and New Developments?Joao A. Osso, IAEA
17.40 – 18.00
Supply of Medical Radioisotopes?Kevin Charlton, Nuclear Development Division, OECD/NEA